294 results on '"Haynes, Anne‐Maree"'
Search Results
2. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography
3. Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy
4. African-specific molecular taxonomy of prostate cancer
5. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study
6. Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers
7. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes
8. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE)
9. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort
10. Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
11. Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy
12. p53 nuclear accumulation as an early indicator of lethal prostate cancer
13. Supplementary Figure 4 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
14. Supplementary Figure 1 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
15. Supplementary Tables 1-3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
16. Data from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
17. Supplementary Table and Figure Legends from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
18. Supplementary Figure 3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
19. Supplementary Figure 2 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
20. Outcomes for active surveillance are similar for men with favourable risk ISUP-2 to those with ISUP-1 prostate cancer: A pair matched cohort study
21. Salvage irreversible electroporation for radio‐recurrent prostate cancer – the prospective FIRE trial
22. Median 4‐year outcomes of salvage irreversible electroporation for localized radio‐recurrent prostate cancer
23. Additional file 1 of The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer
24. Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial
25. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection
26. Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study
27. Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer
28. Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer
29. A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy
30. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio‐recurrent prostate cancer
31. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long‐term follow‐up
32. Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited
33. How Does Age Affect Urinary Continence following Robot-Assisted Radical Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires
34. Additional file 1 of Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers
35. PREDICTING LOW-RISK PROSTATE CANCER FROM TRANSPERINEAL SATURATION BIOPSIES: MP80-16
36. EXTENT OF PELVIC LYMPH NODE DISSECTION IN LYMPH NODE NEGATIVE PROSTATE CANCER IS SIGNIFICANT IN PREDICTING RISK OF BIOCHEMICAL RECURRENCE: MP57-17
37. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy
38. African-specific prostate cancer molecular taxonomy
39. Salvage Robot-assisted Radical Prostatectomy Following Focal Ablation With Irreversible Electroporation: Feasibility, Oncological and Functional Outcomes
40. Tumor Volume in Insignificant Prostate Cancer: Increasing the Threshold is a Safe Approach to Reduce Over-Treatment
41. Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?
42. The mutational landscape of the mitochondrial genome in prostate cancer: 055
43. Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer
44. MP83-02 COMBINATION OF MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI) AND TRANSPERINEAL TEMPLATE-GUIDED MAPPING BIOPSY (TTMB) OF THE PROSTATE TO IDENTIFY CANDIDATES FOR HEMI-ABLATIVE FOCAL THERAPY
45. MP60-04 QUANTITATIVE ASSESSMENT OF T2-WEIGHTED MRI TO BETTER IDENTIFY PATIENTS WITH PROSTATE CANCER IN A SCREENING POPULATION
46. Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer
47. Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan
48. Outcomes of transperineal template-guided prostate biopsy in 409 patients
49. High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse
50. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.